Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A van der Veer; V H J van der Velden; M E Willemse; P G Hoogeveen; E F Petricoin; H B Beverloo; G Escherich; M A Horstmann; R Pieters; M L den Boer

doi:10.1038/bcj.2014.5

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A van der Veer, V H J van der Velden, M E Willemse, P G Hoogeveen, E F Petricoin, H B Beverloo, G Escherich, M A Horstmann, R Pieters, M L den Boer

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Original language	English
Article number	20145
Pages (from-to)	e181
Journal	Blood cancer journal
Volume	4
Issue number	2
DOIs	https://doi.org/10.1038/bcj.2014.5
Publication status	Published - 14 Feb 2014
Externally published	Yes

Access to Document

10.1038/bcj.2014.5

Cite this

van der Veer, A., van der Velden, V. H. J., Willemse, M. E., Hoogeveen, P. G., Petricoin, E. F., Beverloo, H. B., Escherich, G., Horstmann, M. A., Pieters, R., & den Boer, M. L. (2014). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood cancer journal, 4(2), e181. Article 20145. https://doi.org/10.1038/bcj.2014.5

@article{2058d6d97b7f4a268c86c7dd4227e836,

title = "Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia",

author = "{van der Veer}, A and {van der Velden}, {V H J} and Willemse, {M E} and Hoogeveen, {P G} and Petricoin, {E F} and Beverloo, {H B} and G Escherich and Horstmann, {M A} and R Pieters and {den Boer}, {M L}",

note = "Funding Information: This work was supported by the Dutch Cancer Society (KWF, grant EMCR 2007-3718 to MLDB and RP, grant EMCR 2006-3547 to VHJVDV), the Sophia Foundation for Scientific Research (SSWO, grant 658; AVDV, MLDB) and the Pediatric Oncology Foundation Rotterdam (MLDB, RP). These funding sources had no role in the collection, analysis or interpretation of the results, or in writing the manuscript and the decision for submission of this manuscript.",

year = "2014",

month = feb,

day = "14",

doi = "10.1038/bcj.2014.5",

language = "English",

volume = "4",

pages = "e181",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "2",

}

van der Veer, A, van der Velden, VHJ, Willemse, ME, Hoogeveen, PG, Petricoin, EF, Beverloo, HB, Escherich, G, Horstmann, MA, Pieters, R & den Boer, ML 2014, 'Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia', Blood cancer journal, vol. 4, no. 2, 20145, pp. e181. https://doi.org/10.1038/bcj.2014.5

TY - JOUR

T1 - Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

AU - van der Veer, A

AU - van der Velden, V H J

AU - Willemse, M E

AU - Hoogeveen, P G

AU - Petricoin, E F

AU - Beverloo, H B

AU - Escherich, G

AU - Horstmann, M A

AU - Pieters, R

AU - den Boer, M L

N1 - Funding Information: This work was supported by the Dutch Cancer Society (KWF, grant EMCR 2007-3718 to MLDB and RP, grant EMCR 2006-3547 to VHJVDV), the Sophia Foundation for Scientific Research (SSWO, grant 658; AVDV, MLDB) and the Pediatric Oncology Foundation Rotterdam (MLDB, RP). These funding sources had no role in the collection, analysis or interpretation of the results, or in writing the manuscript and the decision for submission of this manuscript.

PY - 2014/2/14

Y1 - 2014/2/14

UR - http://www.scopus.com/inward/record.url?scp=84895452149&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.5

DO - 10.1038/bcj.2014.5

M3 - Article

C2 - 24531445

SN - 2044-5385

VL - 4

SP - e181

JO - Blood cancer journal

JF - Blood cancer journal

IS - 2

M1 - 20145

ER -